No products in the cart.

No products in the wishlist.

We deliver to:

🇦🇺 Australia

🇨🇦 Canada

🇨🇿 Czechia

🇩🇰 Denmark

🇪🇪 Estonia

🇮🇪 Ireland

🇮🇱 Israel

🇮🇹 Italy

🇯🇵 Japan

🇲🇽 Mexico

🇵🇱 Poland

🇸🇰 Slovakia

🇰🇷 South Korea

🇨🇭 Switzerland

🇬🇧 United Kingdom

🇺🇸 United States of America

and more

  • Valacyclovir
  • Valacyclovir

Please note: The product packaging may vary from the images shown. The contents, ingredients, and quality of the product remain unchanged.

Valacyclovir Hetero film-coated tablets 500 mg 2 blisters of 5 pcs.

$23.87

Free Worldwide Shipping

to: Australia, Canada, Czechia, Denmark, Estonia, Ireland, Israel, Italy, Japan, Mexico, Poland, Slovakia, South Korea, Switzerland, United Kingdom, United States and more

In stock

Valacyclovir Hetero 500 mg tablets are an antiviral for herpes infections, shingles, CMV prevention and suppression of recurrent HSV transmission.

Categories: Brand:

Can’t find it? Ask us via WhatsApp, Telegram, Viber or chat

Payment

PayPal, Debit or Credit card, Google Pay, Apple Pay

or

Valacyclovir Hetero tablets are prescribed for the following indications:

  • Treatment of shingles (Herpes zoster).
  • Treatment of infections of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes.
  • Treatment of labial herpes (cold sores).
  • Preventive treatment (suppression) of recurrences of skin and mucous membrane infections caused by the herpes simplex virus, including genital herpes.
  • Reducing transmission of genital herpes virus to a healthy partner when using valacyclovir as suppressive therapy in combination with safe sex.
  • Prevention of cytomegalovirus infection and disease after organ transplantation.

Composition

active ingredient: valacyclovir;

1 tablet contains 500 mg of valacyclovir (as valacyclovir hydrochloride);

excipients: microcrystalline cellulose, crospovidone, povidone, magnesium stearate; coating: Opadry White YS-1-7003 (titanium dioxide (E 171), hypromellose, polyethylene glycol 400, polysorbate 80).

Contraindication

Valacyclovir is contraindicated in patients with hypersensitivity to valacyclovir, acyclovir, or any component of the drug.

Method of application

Treatment of herpes zoster: adults should take 1000 mg (2 tablets) of the drug 3 times a day for 7 days.

Application features

Pregnant women

Valacyclovir should only be used in pregnant women if the potential benefit to the mother outweighs the potential risk to the fetus.

Children

It is used in children aged 12 years and older to prevent cytomegalovirus infection and disease.

Drivers

There are no clinical trial data on this issue, and the pharmacology of valacyclovir does not suggest any adverse effects. However, when assessing a patient’s ability to drive or operate machinery, the patient’s clinical condition and the side-effect profile of valacyclovir should be taken into account.

Overdose

Acute renal failure and neurological symptoms, including confusion, hallucinations, agitation, decreased mental status, and coma, have been reported with valaciclovir overdose. Nausea and vomiting may occur. Caution should be exercised when administering valaciclovir to patients with renal impairment or the elderly, in whom the dose was not reduced appropriately.

Adverse reactions

The most common adverse reactions reported in clinical trials were headache and nausea. More serious adverse reactions included reports of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, acute renal failure, and neurological disorders.

Interaction

Caution should also be exercised (with monitoring of changes in renal function) when co-administering high doses of valacyclovir (4 g or more) and other drugs that affect renal function (e.g. cyclosporine, tacrolimus).

Storage conditions

Store in the original packaging at a temperature not exceeding 25ºС, out of the reach of children.

Reviews

There are no reviews yet.

Be the first to review “Valacyclovir Hetero film-coated tablets 500 mg 2 blisters of 5 pcs.”

Your email address will not be published. Required fields are marked